activins has been researched along with Insulin Sensitivity in 14 studies
Activins: Activins are produced in the pituitary, gonads, and other tissues. By acting locally, they stimulate pituitary FSH secretion and have diverse effects on cell differentiation and embryonic development. Activins are glycoproteins that are hetero- or homodimers of INHIBIN-BETA SUBUNITS.
Excerpt | Relevance | Reference |
---|---|---|
" In the total cohort, fasting plasma Fst correlated positively with fasting plasma glucose, serum insulin and C-peptide levels, homeostasis model assessment of insulin resistance, and hepatic and adipose tissue insulin resistance after adjusting for age, gender and group (all r > 0." | 3.96 | Circulating Follistatin and Activin A and Their Regulation by Insulin in Obesity and Type 2 Diabetes. ( Højlund, K; Kruse, R; Møller, PM; Richter, EA; Sylow, L; Vind, BF; Wojtaszewski, JFP, 2020) |
"Preeclampsia is a major cause of maternal morbidity and mortality worldwide." | 2.44 | Novel biomarkers for predicting preeclampsia. ( Carty, DM; Delles, C; Dominiczak, AF, 2008) |
"The development of insulin resistance is tightly linked to fatty liver disease and is considered a major health concern worldwide, although their mechanistic relationship remains controversial." | 1.39 | Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice. ( Bonomi, LM; Brown, ML; Schneyer, AL; Ungerleider, NA, 2013) |
"Consequently, their role in type 2 diabetes (T2D) was examined." | 1.38 | Correlation between blood activin levels and clinical parameters of type 2 diabetes. ( Allan, CA; Chen, Y; Hedger, MP; Phillips, DJ; Wu, H; Wu, M, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 1 (7.14) | 29.6817 |
2010's | 10 (71.43) | 24.3611 |
2020's | 2 (14.29) | 2.80 |
Authors | Studies |
---|---|
Perakakis, N | 1 |
Kokkinos, A | 1 |
Peradze, N | 1 |
Tentolouris, N | 1 |
Ghaly, W | 1 |
Tsilingiris, D | 1 |
Alexandrou, A | 1 |
Mantzoros, CS | 1 |
Sylow, L | 1 |
Vind, BF | 1 |
Kruse, R | 1 |
Møller, PM | 1 |
Wojtaszewski, JFP | 1 |
Richter, EA | 1 |
Højlund, K | 1 |
Hashimoto, O | 2 |
Funaba, M | 2 |
Sekiyama, K | 2 |
Doi, S | 1 |
Shindo, D | 1 |
Satoh, R | 1 |
Itoi, H | 1 |
Oiwa, H | 1 |
Morita, M | 1 |
Suzuki, C | 1 |
Sugiyama, M | 1 |
Yamakawa, N | 1 |
Takada, H | 1 |
Matsumura, S | 1 |
Inoue, K | 1 |
Oyadomari, S | 1 |
Sugino, H | 1 |
Kurisaki, A | 2 |
Ushiro, Y | 1 |
Ungerleider, NA | 1 |
Bonomi, LM | 1 |
Brown, ML | 1 |
Schneyer, AL | 1 |
Blumensatt, M | 1 |
Greulich, S | 2 |
Herzfeld de Wiza, D | 1 |
Mueller, H | 2 |
Maxhera, B | 1 |
Rabelink, MJ | 1 |
Hoeben, RC | 1 |
Akhyari, P | 1 |
Al-Hasani, H | 1 |
Ruige, JB | 1 |
Ouwens, DM | 2 |
Boström, PA | 1 |
Fernández-Real, JM | 1 |
Nomura, M | 1 |
Morinaga, H | 1 |
Zhu, HL | 1 |
Wang, L | 1 |
Hasuzawa, N | 1 |
Takayanagi, R | 1 |
Teramoto, N | 1 |
Brandt, C | 1 |
Hansen, RH | 1 |
Hansen, JB | 1 |
Olsen, CH | 1 |
Galle, P | 1 |
Mandrup-Poulsen, T | 1 |
Gehl, J | 1 |
Pedersen, BK | 1 |
Hojman, P | 1 |
Carty, DM | 1 |
Delles, C | 1 |
Dominiczak, AF | 1 |
de Wiza, DH | 1 |
Preilowski, S | 1 |
Ding, Z | 1 |
Langin, D | 1 |
Jaquet, K | 1 |
Eckel, J | 1 |
Bonomi, L | 1 |
Brown, M | 1 |
Ungerleider, N | 1 |
Muse, M | 1 |
Matzuk, MM | 1 |
Schneyer, A | 1 |
Wu, H | 1 |
Wu, M | 1 |
Chen, Y | 1 |
Allan, CA | 1 |
Phillips, DJ | 1 |
Hedger, MP | 1 |
Laivuori, H | 1 |
Kaaja, R | 1 |
Turpeinen, U | 1 |
Stenman, UH | 1 |
Ylikorkala, O | 1 |
1 review available for activins and Insulin Sensitivity
Article | Year |
---|---|
Novel biomarkers for predicting preeclampsia.
Topics: Activins; Angiogenesis Inducing Agents; Antigens, CD; Apolipoproteins E; Biomarkers; Endoglin; Femal | 2008 |
13 other studies available for activins and Insulin Sensitivity
Article | Year |
---|---|
Metabolic regulation of activins in healthy individuals and in obese patients undergoing bariatric surgery.
Topics: Activins; Bariatric Surgery; Biomarkers; Blood Glucose; Case-Control Studies; Diabetes Mellitus, Typ | 2020 |
Circulating Follistatin and Activin A and Their Regulation by Insulin in Obesity and Type 2 Diabetes.
Topics: Activins; Blood Glucose; C-Peptide; Case-Control Studies; Diabetes Mellitus, Type 2; Fasting; Female | 2020 |
Activin E Controls Energy Homeostasis in Both Brown and White Adipose Tissues as a Hepatokine.
Topics: Activin Receptors, Type I; Activins; Adipocytes, Beige; Adipocytes, Brown; Adipose Tissue, Brown; Ad | 2018 |
Activin E enhances insulin sensitivity and thermogenesis by activating brown/beige adipocytes.
Topics: Actins; Activins; Adipocytes, Beige; Adipocytes, Brown; Adipose Tissue, Brown; Adipose Tissue, White | 2019 |
Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice.
Topics: Activins; Animals; Biological Availability; Cells, Cultured; Fatty Liver; Follistatin-Related Protei | 2013 |
Activin A impairs insulin action in cardiomyocytes via up-regulation of miR-143.
Topics: Activins; Adipokines; Animals; Cells, Cultured; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies | 2013 |
Metabolism: Irisin, the metabolic syndrome and follistatin in humans.
Topics: Activins; Female; Fibronectins; Follistatin; Humans; Insulin Resistance; Male; Metabolic Syndrome; M | 2014 |
Activation of activin type IB receptor signals in pancreatic β cells leads to defective insulin secretion through the attenuation of ATP-sensitive K+ channel activity.
Topics: Activin Receptors, Type I; Activins; Animals; Cells, Cultured; Glucose; Insulin; Insulin Resistance; | 2014 |
Over-expression of Follistatin-like 3 attenuates fat accumulation and improves insulin sensitivity in mice.
Topics: Activins; Adiposity; Animals; Diet, High-Fat; Female; Follistatin-Related Proteins; Glucagon; Glucos | 2015 |
Secretory products of guinea pig epicardial fat induce insulin resistance and impair primary adult rat cardiomyocyte function.
Topics: Activins; Animals; Calcium; Cardiovascular Diseases; Cells, Cultured; Diabetes Mellitus, Type 2; Die | 2011 |
Activin B regulates islet composition and islet mass but not whole body glucose homeostasis or insulin sensitivity.
Topics: Activins; Aging; Animals; Blood Glucose; Cell Count; Follistatin; Glucagon-Secreting Cells; Homeosta | 2012 |
Correlation between blood activin levels and clinical parameters of type 2 diabetes.
Topics: Activins; Adult; Aged; Biomarkers; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Type 2; Fas | 2012 |
Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity.
Topics: Activins; Adult; Biomarkers; Female; Gestational Age; Humans; Inhibins; Insulin Resistance; Peptides | 1999 |